Correction to: Visual attention and inhibitory control in children, teenagers and adults with autism without intellectual disability: results of oculomotor tasks from a 2-year longitudinal follow-up study (InFoR)
Molecular Autism. 2022-01-05; 13(1):
DOI: 10.1186/s13229-021-00479-x
Lire sur PubMed
1. Mol Autism. 2022 Jan 5;13(1):4. doi: 10.1186/s13229-021-00479-x.
Correction to: Visual attention and inhibitory control in children, teenagers and
adults with autism without intellectual disability: results of oculomotor tasks
from a 2-year longitudinal follow-up study (InFoR).
Amestoy A(1)(2)(3), Guillaud E(4), Bucchioni G(4)(5), Zalla T(6), Umbricht D(7),
Chatham C(7), Murtagh L(7), Houenou J(8)(9), Delorme R(8)(10)(11), Moal ML(12),
Leboyer M(13)(8)(11), Bouvard M(4)(8)(14), Cazalets JR(4).
Author information:
(1)CNRS, Aquitaine Institute for Cognitive and Integrative Neuroscience, INCIA,
UMR 5287, Université de Bordeaux, 33000, Bordeaux, France.
.
(2)Fondation FondaMental, Créteil, France. .
(3)Centre Hospitalier Charles-Perrens, Pôle Universitaire de Psychiatrie de
L’enfant Et de L’adolescent, 121, rue de la Béchade, CS 81285, 33076, Bordeaux
Cedex, France. .
(4)CNRS, Aquitaine Institute for Cognitive and Integrative Neuroscience, INCIA,
UMR 5287, Université de Bordeaux, 33000, Bordeaux, France.
(5)iBrain, UMR 1253 Inserm, Université de Tours, 2 Boulevard Tonnellé, 37044,
Tours Cedex, France.
(6)Institut Jean Nicod, ENS, Paris, France.
(7)Roche Pharma Research and Early Development, Roche Innovation Center Basel, F.
Hofmann-La Roche Ltd., Grenzacherstrasse 124, 4070, Basel, Switzerland.
(8)Fondation FondaMental, Créteil, France.
(9)NeuroSpin, UNIACT Lab, Equipe de Psychiatrie, Commissariat À L’énergie
Atomique, Saclay, Gif-sur-Yvette, France.
(10)Institut Pasteur, Paris, France.
(11)AP-HP, DMU IMPACT, Psychiatry and Addictology Department, Mondor University
Hospital, Université Paris Est Créteil, Créteil, France.
(12)Institut Roche, Tour Horizons-Bureau 18M3, Roche S.A.S., 30, cours de l’île
Seguin, 92650, Boulogne-Billancourt, France.
(13)Laboratoire de NeuroPsychiatrie Translationnelle, INSERM, U955, IMRB,
Créteil, France.
(14)Centre Hospitalier Charles-Perrens, Pôle Universitaire de Psychiatrie de
L’enfant Et de L’adolescent, 121, rue de la Béchade, CS 81285, 33076, Bordeaux
Cedex, France.
Erratum for
Mol Autism. 2021 Nov 13;12(1):71.
DOI: 10.1186/s13229-021-00479-x
PMCID: PMC8728898
PMID: 34986873